Pharma Leaders ForumsTuesday, 29 April 2025 - GMT (Greenwich Mean Time, GMTZ)

Morning Session. Chaired private and exclusive roundtable series.

11.10am (1hr 40mins) Roundtable One

- M&A, deal environment, anti-trust landscape analysis, general discussion and peer commentary from BD heads

11am Introductions

11.15 Current and Impending Anti-trust and Regulatory Threats

General Discussion and Peer Perspectives

• Perceptions and perspectives on current deal making environment: what are BD heads observing and how are they responding?
• How should big pharma M&A strategies evolve given the regulatory and anti-trust context?

For further information regarding the Pharma BD Leaders Forum, please contact:

Matthew Pullan, Managing Director, LSX

matt@lsxleaders.com

2pm (1hr 40 mins) Roundtable Two – Global BD Heads only

Pier discussion and exploration of solutions to presented challenges.

Potential topics to include:

• IRA developments
• M&A landscape
• Current challenges and success stories
• Anti-trust
• Regulatory update
• AI and relevance, impact on dealmaking

For further information regarding the Pharma BD Leaders Forum, please contact:

Matthew Pullan, Managing Director, LSX

matt@lsxleaders.com

Leaders Forums